GAF Healthcare

Best Hematologists for Aplastic Anemia Immunosuppressive Therapy in India

This page lists 1 aplastic anemia immunosuppressive therapy doctor in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 1 aplastic anemia immunosuppressive therapy doctor in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Aplastic Anemia Immunosuppressive Therapy doctors in India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Aplastic Anemia Immunosuppressive Therapy doctors

Image not available Featured

Dr. Garima Nirmal

MBBS, MD, DM (Haematology)
Senior Consultant — Paediatric Haematology · Specialty: Paediatric Haematologist
Apollo Hospitals Indraprastha New Delhi, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Paediatric Haematologist
  • Senior Consultant, Paediatric Haematology, Apollo Hospitals Indraprastha, New Delhi
  • Specialist in paediatric haematological disorders with focus on bone marrow transplantation and complex blood disorders management
Expertise & Procedures
  • Bone Marrow Biopsy and Aspiration
  • Pediatric Leukemia Management and Chemotherapy
  • Sickle Cell Disease Management
  • Thalassemia Treatment Planning
  • Aplastic Anemia Immunosuppressive Therapy
View all procedures →
Paediatric Haematologist Experience: 10+ YearsHospital Affiliation: Apollo Hospitals IndraprasthaHospital accreditation: JCI, NABH
View Profile Book a Consultation

Hospitals where these doctors practise

Apollo Hospitals🇮🇳 New Delhi, India
Starting from$9,000

Apollo Hospitals

Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Aplastic Anemia Immunosuppressive TherapyHematologyCardiac SurgeryCardiology
1+
Doctors for Aplastic Anemia Immunosuppressive Therapy
4.9
1240 reviews
1000+
Beds
43+
Years Since Founded
Dr. Garima Nirmal
View Hospital Profile Enquire / Get Free Opinion

Why consider treatment in India?

Many international patients consider India for aplastic anemia treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Aplastic Anemia Immunosuppressive Therapy?

Immunosuppressive Therapy (IST) is a non-transplant treatment for Aplastic Anemia that uses medications like Anti-Thymocyte Globulin (ATG) and Cyclosporine to suppress the abnormal immune response attacking the bone marrow, allowing blood cell production to recover. It is typically recommended for patients who lack a suitable matched donor for bone marrow transplant or who are not fit for transplant due to age or other health conditions. The therapy requires inpatient monitoring during ATG infusion followed by long-term oral medication and regular blood monitoring.

Who may be considered?

Aplastic Anemia Immunosuppressive Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

A combination of intravenous rabbit or horse Anti-Thymocyte Globulin given over several days in hospital, followed by daily oral Cyclosporine for several months to a year, along with corticosteroids to reduce infusion reactions.

2 approaches available for this procedure:

Standard IST with ATG and Cyclosporine

Most Common

A combination of intravenous rabbit or horse Anti-Thymocyte Globulin given over several days in hospital, followed by daily oral Cyclosporine for several months to a year, along with corticosteroids to reduce infusion reactions.

Comprehensive Investigations

Estimated cost: $400 - $900

CBC with reticulocyte count, bone marrow biopsy and aspiration, cytogenetics, HLA typing, PNH clone testing by flow cytometry, viral serology (HIV, Hepatitis B/C), liver and kidney function tests, ECG, chest X-ray

Treatment / Procedure Estimate

Estimated cost in India: $9,000 - $15,000

Stay in India

Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: ~7-10 days
Recovery period (outside hospital): ~15-30 days recommended
Total stay: approx 20-35 days

Usually Included in Hospital Package

  • Hematologist and transplant physician consultations
  • ATG infusion with continuous cardiac and vital monitoring
  • Premedication and steroid cover to reduce serum sickness risk
  • Daily blood counts and supportive transfusions if needed
  • Initial supply of oral Cyclosporine with dose adjustment

Usually Not Included

  • Long-term Cyclosporine medication after discharge
  • Blood/platelet transfusions before admission
  • Accommodation for attendant/companion
  • Post-discharge follow-up blood tests in home country
  • Treatment for infections unrelated to therapy

Recovery and follow-up

Response to IST may take 3 to 6 months, requiring regular CBC monitoring and Cyclosporine dose adjustments through local hematology follow-up, with periodic communication with the treating Indian center.

Risks

Risks include infusion reactions and serum sickness from ATG, increased susceptibility to infections due to immunosuppression, kidney or liver toxicity from Cyclosporine, and the possibility of incomplete or delayed response requiring further treatment.

Alternatives

Alternatives include allogeneic bone marrow or stem cell transplant for eligible patients with a matched donor, or supportive care with regular blood and platelet transfusions for patients unfit for either IST or transplant.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Complete blood count (CBC) with differential and reticulocyte count
  • Bone marrow aspiration and biopsy report
  • Cytogenetic and molecular test results
  • PNH clone flow cytometry report
  • HLA typing report (patient and potential siblings)
  • Viral serology panel (HIV, Hepatitis B/C, CMV)
  • Liver and kidney function test reports
  • Recent physician consultation notes and treatment history

Patient information needed

  • Age and current weight of the patient
  • Severity classification of aplastic anemia (moderate/severe/very severe)
  • History of prior transfusions and any transfusion reactions
  • Availability of an HLA-matched sibling donor, if any
  • Any known allergies to horse or rabbit-derived proteins
  • Current medications and comorbid conditions
  • Recent infection history or active fevers
  • Preferred travel dates and accompanying attendant details

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Aplastic Anemia Immunosuppressive Therapy) and procedure (Aplastic Anemia Immunosuppressive Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Aplastic Anemia Immunosuppressive Therapy in India

What is Aplastic Anemia?
Aplastic anemia is a condition in which the bone marrow fails to produce sufficient blood cells of all types—red cells, white cells, and platelets—most commonly because the immune system mistakenly attacks the blood-forming stem cells within the marrow. It ranges from mild to very severe and requires medical evaluation to determine the right course of management.
What are the symptoms and health risks of Aplastic Anemia?
People with aplastic anemia may experience persistent fatigue, shortness of breath, and pallor due to low red blood cell counts; frequent or unusually severe infections from low white blood cell counts; and easy bruising, prolonged bleeding from minor cuts, or small red spots under the skin (petechiae) caused by low platelets. Some individuals have subtle symptoms for months before diagnosis, while others present more acutely. These symptoms overlap with many other blood and bone marrow disorders, so a clinical assessment—not symptoms alone—is needed to establish a diagnosis.
How is Aplastic Anemia diagnosed?
Diagnosis typically begins with a full blood count (FBC) revealing low levels across all three blood cell lines (pancytopenia), followed by a bone marrow aspirate and trephine biopsy to confirm reduced or absent marrow cellularity. Severity is classified as non-severe, severe, or very severe aplastic anemia based on established hematological criteria—principally neutrophil count, platelet count, and reticulocyte count—which directly influence treatment decisions. Additional tests, including chromosomal analysis and screening for underlying causes such as paroxysmal nocturnal hemoglobinuria (PNH) or inherited bone marrow failure syndromes, are commonly performed to refine diagnosis and plan treatment.
How is Aplastic Anemia treated?
The appropriate treatment for aplastic anemia depends on disease severity, the patient's age, overall health, and the availability of a suitable donor, and should be determined through individual assessment by a qualified specialist. Severe and very severe aplastic anemia in younger, fit patients is often treated with allogeneic bone marrow (stem cell) transplantation, which offers the potential for long-term cure, particularly when a well-matched related donor is available. For patients who are not transplant candidates—due to age, comorbidities, or lack of a suitable donor—immunosuppressive therapy using agents such as anti-thymocyte globulin (ATG) combined with ciclosporin is a well-established alternative, and other targeted treatments may also be considered depending on individual circumstances.
Can Aplastic Anemia be treated without a procedure?
Non-surgical management plays a central and evidence-based role in aplastic anemia. Immunosuppressive therapy (IST)—combining anti-thymocyte globulin, ciclosporin, and in some protocols eltrombopag—is a standard first-line approach for patients who are not eligible for transplantation and can achieve meaningful responses in many cases. Supportive care, including red cell and platelet transfusions, infection prevention, and growth factor support, is used across all severity levels to stabilize the patient while a definitive treatment plan is established.
When is Aplastic Anemia Immunosuppressive Therapy considered for Aplastic Anemia?
Aplastic Anemia Immunosuppressive Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Aplastic Anemia?
Aplastic anemia is primarily evaluated and managed by a hematologist with experience in bone marrow failure disorders; when transplantation is indicated, care is coordinated with or transferred to a bone marrow transplant (BMT) physician and a dedicated transplant team. Patients with very severe disease or those being considered for transplant are best served at centers with an accredited BMT program and multidisciplinary hematology support.
How do I choose a doctor for Aplastic Anemia?
When comparing providers for aplastic anemia, look for a hematologist or BMT center with documented experience in bone marrow failure syndromes, access to a full range of donor sources (matched related, matched unrelated, and alternative donors), and robust supportive care infrastructure including infectious disease and transfusion medicine support. Ask specifically about the center's transplant volume for aplastic anemia, their protocol for immunosuppressive therapy, and the arrangements for long-term follow-up and monitoring for late complications such as relapse or clonal evolution.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.
WhatsApp Us